Optimal use of innovative therapies for autoimmune inflammatory diseases.

Disease areas most studied are rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE).

Methodologies include investigator-initiated clinical trials, (international) registries, and studies based on direct patient contact.

Novel therapeutic strategies (e.g., treat-to-target, induction-maintenance), novel methods of doing clinical trials ('the learning healt care environment'), use of imaging in clinical care, are among the most noted recent topics of the research in my group.